Cannatrek’s mission is to provide better health outcomes for Australians.
The company is a seed to patient enterprise, one of the first in Australia to secure federal licenses to import seed, research, grow, process, distribute and export cannabis to the world.
Rhyme & Reason was engaged to develop a business marketing strategy core to differentiating Cannatrek from other less-evolved, under-licensed, ill-conceived, speculative cannabis propositions. R+R worked directly with the board and VC partners developing the prospectus and go to market strategy.
The resulting documentation and brand identity work outlined the opportunity to invest in this early-stage, high growth business venture operating across the entire medical cannabis value chain.
The industry for Medicinal Cannabis (MC) is growing at pace as governments around the world open legislation to realise the validated health benefits of cannabinoids. As a fully licensed, Australian Medicinal Cannabis enterprise, Cannatrek successfully launched a $5,000,000 funding round prior to its IPO coinciding with its first harvest.
-Tommy Huppert, Cannatrek CEO